Overcoming Resistance to Selective Serotonin Reuptake Inhibitors: Targeting Serotonin, Serotonin-1A Receptors and Adult Neuroplasticity

Major depressive disorder (MDD) is the most prevalent mental illness contributing to global disease burden. Selective serotonin (5-HT) reuptake inhibitors (SSRIs) are the first-line treatment for MDD, but are only fully effective in 30% of patients and require weeks before improvement may be seen. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Vahid-Ansari, Faranak, Zhang, Min, Zahrai, Amin, Albert, Paul R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6502905/
https://www.ncbi.nlm.nih.gov/pubmed/31114473
http://dx.doi.org/10.3389/fnins.2019.00404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6502905/
https://www.ncbi.nlm.nih.gov/pubmed/31114473
http://dx.doi.org/10.3389/fnins.2019.00404

Ejemplares similares